Skip to main content

Animations

MJFF Publications

6391 - 6400 of 9145 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2016
  • 2020
  • 2019
  • 2016
  • 2024
  • 2024
  • 2011
  • 2009
  • Summary Details
    OPEN
    Title: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29518
    Citation Count: 25
  • Summary Details
    OPEN
    Title: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesis
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pro.4728
    Citation Count: 2
  • Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
    2016
    Summary Details
    RESTRICTED
    Title: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1785746
    Citation Count: 124
  • Summary Details
    OPEN
    Title: The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
    Journal Name: Cell Death & Differentiation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41418-019-0408-4
    Citation Count: 131
  • Summary Details
    OPEN
    Title: A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.04.001
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 32
  • Summary Details
    OPEN
    Title: KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-60602-9
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix Compartments
    Journal Name: Frontiers in Neuroanatomy
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnana.2011.00059
    Citation Count: 85
  • Summary Details
    OPEN
    Title: A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2009.02.009
    Citation Count: 196
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.